- Home
- CRMD vs TCPC Comparison
CRMD vs TCPC Comparison
Compare CRMD & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- TCPC
- Stock Information
- Founded
- CRMD 2006
- TCPC 2012
- Country
- CRMD United States
- TCPC United States
- Employees
- CRMD N/A
- TCPC N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- TCPC Finance/Investors Services
- Sector
- CRMD Health Care
- TCPC Finance
- Exchange
- CRMD Nasdaq
- TCPC Nasdaq
- Market Cap
- CRMD 645.0M
- TCPC 767.3M
- IPO Year
- CRMD 2010
- TCPC 2012
- Fundamental
- Price
- CRMD $10.13
- TCPC $9.45
- Analyst Decision
- CRMD Strong Buy
- TCPC Hold
- Analyst Count
- CRMD 6
- TCPC 7
- Target Price
- CRMD $15.67
- TCPC $8.88
- AVG Volume (30 Days)
- CRMD 906.0K
- TCPC 502.8K
- Earning Date
- CRMD 03-11-2025
- TCPC 02-27-2025
- Dividend Yield
- CRMD N/A
- TCPC 18.62%
- EPS Growth
- CRMD N/A
- TCPC N/A
- EPS
- CRMD N/A
- TCPC N/A
- Revenue
- CRMD $12,262,234.00
- TCPC $249,036,775.00
- Revenue This Year
- CRMD N/A
- TCPC $27.36
- Revenue Next Year
- CRMD $234.92
- TCPC N/A
- P/E Ratio
- CRMD N/A
- TCPC N/A
- Revenue Growth
- CRMD 41184.20
- TCPC 21.38
- 52 Week Low
- CRMD $3.03
- TCPC $7.71
- 52 Week High
- CRMD $13.85
- TCPC $11.52
- Technical
- Relative Strength Index (RSI)
- CRMD 44.90
- TCPC 64.22
- Support Level
- CRMD $9.79
- TCPC $9.30
- Resistance Level
- CRMD $11.28
- TCPC $9.47
- Average True Range (ATR)
- CRMD 0.51
- TCPC 0.14
- MACD
- CRMD -0.05
- TCPC 0.03
- Stochastic Oscillator
- CRMD 23.84
- TCPC 94.44
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
About TCPC BlackRock TCP Capital Corp.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.